Insilico Medicine Company
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Investors
%20.jpg)
%20.jpg)
Connections from
%20.png)
Last Funding Type:
Series D
Funding Status:
Late Stage Venture
Headquarters:
Hong Kong, Hong Kong Island, Hong Kong
Founded Date:
2014-01-01
Last Funding Date:
2022-08-10
Total Funding:
401300000
Employee Number:
101-250
Number Of Exists:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
32
Industry:
Anti-aging Therapies